POST Online Media Lite Edition


Kyowa Kirin appoints Paula Soteropoulos to board

Christian Fernsby |
Bedminster, N.J., USA - KyowarnKirin, a specialty pharmaceutical company, names Paula Soteropoulos, a biopharma industry veteran, as the newest non executive director on its North America board of directors.

Article continues below

Ms. Soteropoulos brings more than three decades of experience across strategic and operational areas including drug development, global commercialization, manufacturing, new company formation and company building.

Ms. Soteropoulos currently serves as Executive Chairman for Ensoma and as a member of the Board of Directors of uniQure, Rallybio and Chiesi USA.

Ms. Soteropoulos previously served as founding CEO and member of the Board of Directors of rare disease therapeutic developer Akcea Therapeutics, where she led the company through its IPO and multiple drug launches.